HER2 overexpression reverses the relative resistance of EGFR-mutant H1975 cell line to gefitinib
Jing Xu(Zhejiang Cancer Hospital), Qichun Wei(Ministry of Education of the People's Republic of China), Shu-Qin Ruan(Zhongshan Hospital), Bicheng Zhang(University of Electronic Science and Technology of China), Li Shen(South China Agricultural University), Wenhong Xu(Shandong University)
Cited by 10
Related Papers
Clinical characteristics of 82 cases of death from COVID-19
|PLoS ONE|2020|594
Declining Risk of Sudden Death in Heart Failure
|New England Journal of Medicine|2017|500
Immune Phenotyping Based on the Neutrophil-to-Lymphocyte Ratio and IgG Level Predicts Disease Severity and Outcome for Patients With COVID-19
|Frontiers in Molecular Biosciences|2020|497
Prognostic Value of C-Reactive Protein in Patients With Coronavirus 2019
|Clinical Infectious Diseases|2020|458
Anti-angiogenic Agents in Combination With Immune Checkpoint Inhibitors: A Promising Strategy for Cancer Treatment
|Frontiers in Immunology|2020|256